Alzheimer’s Disease Diagnostic Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: A9783DD2785EEN
Market Monitor Global

Abstracts

The diagnosis of alzheimer's disease is divided into three steps. The first step is to determine whether it is alzheimer's disease.The second step is to look for the cause, to look for biomarkers such as prolapidin-1, prolapidin-2 and the amyloid gene, amyloid deposition, or hippocampal volume or medial temporal lobe volume atrophy, and the apolipoprotein E4 allele.The third step is to determine the extent of the disease, which can be determined by a simple mental state examination or the patient's response.

This report contains market size and forecasts of Alzheimer’s Disease Diagnostic in Global, including the following market information:

Global Alzheimer’s Disease Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Alzheimer’s Disease Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Nervous System Examination Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Alzheimer’s Disease Diagnostic include Eli Lilly and Company, Novartis, Merck, F. Hoffmann-La Roche, Pfizer, TauRx, Alector, Accera and Treventis Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer’s Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Alzheimer’s Disease Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer’s Disease Diagnostic Market Segment Percentages, by Type, 2021 (%)

• Nervous System Examination
• Genetic Testing
• Minor Mental State Examination (Mmse)
• Brain Imaging

Global Alzheimer’s Disease Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer’s Disease Diagnostic Market Segment Percentages, by Application, 2021 (%)

• Early-Onset Alzheimer's Disease
• Familial Alzheimer's Disease
• Late-Onset Alzheimer's Disease

Global Alzheimer’s Disease Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Alzheimer’s Disease Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Alzheimer’s Disease Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Alzheimer’s Disease Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly and Company
• Novartis
• Merck
• F. Hoffmann-La Roche
• Pfizer
• TauRx
• Alector
• Accera
• Treventis Corporation
• Neuro-Bio
• Cognition Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Alzheimer’s Disease Diagnostic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Alzheimer’s Disease Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC OVERALL MARKET SIZE

2.1 Global Alzheimer’s Disease Diagnostic Market Size: 2021 VS 2028
2.2 Global Alzheimer’s Disease Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Alzheimer’s Disease Diagnostic Players in Global Market
3.2 Top Global Alzheimer’s Disease Diagnostic Companies Ranked by Revenue
3.3 Global Alzheimer’s Disease Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer’s Disease Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alzheimer’s Disease Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer’s Disease Diagnostic Players in Global Market
  3.6.1 List of Global Tier 1 Alzheimer’s Disease Diagnostic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Alzheimer’s Disease Diagnostic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Alzheimer’s Disease Diagnostic Market Size Markets, 2021 & 2028
  4.1.2 Nervous System Examination
  4.1.3 Genetic Testing
  4.1.4 Minor Mental State Examination (Mmse)
  4.1.5 Brain Imaging
4.2 By Type - Global Alzheimer’s Disease Diagnostic Revenue & Forecasts
  4.2.1 By Type - Global Alzheimer’s Disease Diagnostic Revenue, 2017-2022
  4.2.2 By Type - Global Alzheimer’s Disease Diagnostic Revenue, 2023-2028
  4.2.3 By Type - Global Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Alzheimer’s Disease Diagnostic Market Size, 2021 & 2028
  5.1.2 Early-Onset Alzheimer's Disease
  5.1.3 Familial Alzheimer's Disease
  5.1.4 Late-Onset Alzheimer's Disease
5.2 By Application - Global Alzheimer’s Disease Diagnostic Revenue & Forecasts
  5.2.1 By Application - Global Alzheimer’s Disease Diagnostic Revenue, 2017-2022
  5.2.2 By Application - Global Alzheimer’s Disease Diagnostic Revenue, 2023-2028
  5.2.3 By Application - Global Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Alzheimer’s Disease Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Alzheimer’s Disease Diagnostic Revenue & Forecasts
  6.2.1 By Region - Global Alzheimer’s Disease Diagnostic Revenue, 2017-2022
  6.2.2 By Region - Global Alzheimer’s Disease Diagnostic Revenue, 2023-2028
  6.2.3 By Region - Global Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Alzheimer’s Disease Diagnostic Revenue, 2017-2028
  6.3.2 US Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.3.3 Canada Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.3.4 Mexico Alzheimer’s Disease Diagnostic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Alzheimer’s Disease Diagnostic Revenue, 2017-2028
  6.4.2 Germany Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.4.3 France Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.4.4 U.K. Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.4.5 Italy Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.4.6 Russia Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.4.7 Nordic Countries Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.4.8 Benelux Alzheimer’s Disease Diagnostic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Alzheimer’s Disease Diagnostic Revenue, 2017-2028
  6.5.2 China Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.5.3 Japan Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.5.4 South Korea Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.5.5 Southeast Asia Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.5.6 India Alzheimer’s Disease Diagnostic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Alzheimer’s Disease Diagnostic Revenue, 2017-2028
  6.6.2 Brazil Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.6.3 Argentina Alzheimer’s Disease Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Alzheimer’s Disease Diagnostic Revenue, 2017-2028
  6.7.2 Turkey Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.7.3 Israel Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.7.4 Saudi Arabia Alzheimer’s Disease Diagnostic Market Size, 2017-2028
  6.7.5 UAE Alzheimer’s Disease Diagnostic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly and Company
  7.1.1 Eli Lilly and Company Corporate Summary
  7.1.2 Eli Lilly and Company Business Overview
  7.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Major Product Offerings
  7.1.4 Eli Lilly and Company Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly and Company Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Alzheimer’s Disease Diagnostic Major Product Offerings
  7.2.4 Novartis Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Alzheimer’s Disease Diagnostic Major Product Offerings
  7.3.4 Merck Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 F. Hoffmann-La Roche
  7.4.1 F. Hoffmann-La Roche Corporate Summary
  7.4.2 F. Hoffmann-La Roche Business Overview
  7.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Major Product Offerings
  7.4.4 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.4.5 F. Hoffmann-La Roche Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Alzheimer’s Disease Diagnostic Major Product Offerings
  7.5.4 Pfizer Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 TauRx
  7.6.1 TauRx Corporate Summary
  7.6.2 TauRx Business Overview
  7.6.3 TauRx Alzheimer’s Disease Diagnostic Major Product Offerings
  7.6.4 TauRx Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.6.5 TauRx Key News
7.7 Alector
  7.7.1 Alector Corporate Summary
  7.7.2 Alector Business Overview
  7.7.3 Alector Alzheimer’s Disease Diagnostic Major Product Offerings
  7.7.4 Alector Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.7.5 Alector Key News
7.8 Accera
  7.8.1 Accera Corporate Summary
  7.8.2 Accera Business Overview
  7.8.3 Accera Alzheimer’s Disease Diagnostic Major Product Offerings
  7.8.4 Accera Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.8.5 Accera Key News
7.9 Treventis Corporation
  7.9.1 Treventis Corporation Corporate Summary
  7.9.2 Treventis Corporation Business Overview
  7.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Major Product Offerings
  7.9.4 Treventis Corporation Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.9.5 Treventis Corporation Key News
7.10 Neuro-Bio
  7.10.1 Neuro-Bio Corporate Summary
  7.10.2 Neuro-Bio Business Overview
  7.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Major Product Offerings
  7.10.4 Neuro-Bio Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.10.5 Neuro-Bio Key News
7.11 Cognition Therapeutics
  7.11.1 Cognition Therapeutics Corporate Summary
  7.11.2 Cognition Therapeutics Business Overview
  7.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Major Product Offerings
  7.11.4 Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue in Global Market (2017-2022)
  7.11.5 Cognition Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Alzheimer’s Disease Diagnostic Market Opportunities & Trends in Global Market
Table 2. Alzheimer’s Disease Diagnostic Market Drivers in Global Market
Table 3. Alzheimer’s Disease Diagnostic Market Restraints in Global Market
Table 4. Key Players of Alzheimer’s Disease Diagnostic in Global Market
Table 5. Top Alzheimer’s Disease Diagnostic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alzheimer’s Disease Diagnostic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alzheimer’s Disease Diagnostic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alzheimer’s Disease Diagnostic Product Type
Table 9. List of Global Tier 1 Alzheimer’s Disease Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer’s Disease Diagnostic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alzheimer’s Disease Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alzheimer’s Disease Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alzheimer’s Disease Diagnostic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alzheimer’s Disease Diagnostic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alzheimer’s Disease Diagnostic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alzheimer’s Disease Diagnostic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly and Company Corporate Summary
Table 31. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product Offerings
Table 32. Eli Lilly and Company Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Alzheimer’s Disease Diagnostic Product Offerings
Table 35. Novartis Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Alzheimer’s Disease Diagnostic Product Offerings
Table 38. Merck Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 39. F. Hoffmann-La Roche Corporate Summary
Table 40. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product Offerings
Table 41. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Alzheimer’s Disease Diagnostic Product Offerings
Table 44. Pfizer Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 45. TauRx Corporate Summary
Table 46. TauRx Alzheimer’s Disease Diagnostic Product Offerings
Table 47. TauRx Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 48. Alector Corporate Summary
Table 49. Alector Alzheimer’s Disease Diagnostic Product Offerings
Table 50. Alector Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 51. Accera Corporate Summary
Table 52. Accera Alzheimer’s Disease Diagnostic Product Offerings
Table 53. Accera Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 54. Treventis Corporation Corporate Summary
Table 55. Treventis Corporation Alzheimer’s Disease Diagnostic Product Offerings
Table 56. Treventis Corporation Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 57. Neuro-Bio Corporate Summary
Table 58. Neuro-Bio Alzheimer’s Disease Diagnostic Product Offerings
Table 59. Neuro-Bio Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)
Table 60. Cognition Therapeutics Corporate Summary
Table 61. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product Offerings
Table 62. Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Alzheimer’s Disease Diagnostic Segment by Type in 2021
Figure 2. Alzheimer’s Disease Diagnostic Segment by Application in 2021
Figure 3. Global Alzheimer’s Disease Diagnostic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alzheimer’s Disease Diagnostic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alzheimer’s Disease Diagnostic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alzheimer’s Disease Diagnostic Revenue in 2021
Figure 8. By Type - Global Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 12. US Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 16. Germany Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 17. France Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 24. China Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 28. India Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 30. Brazil Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alzheimer’s Disease Diagnostic Revenue Market Share, 2017-2028
Figure 33. Turkey Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alzheimer’s Disease Diagnostic Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly and Company Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. TauRx Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Alector Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Accera Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Treventis Corporation Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Neuro-Bio Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)